Timothy A. Springer
Independent DirectorDr. Timothy A. Springer, also known as Tim, Ph.D., M.B.A., is Trustee of The Marine Biological Laboratory. Dr. Springer founded Morphic Holding, Inc. in August 2014 and serves as its Scientific Advisor and a Director since June 2015. He serves as Independent Director at Cartesian Therapeutics, Inc. since June 2016 and was its scientific advisor since December 2008. He is Independent Director at Tectonic Therapeutic, Inc since June 2019. Dr. Springer is Founder of Morphic Rock Therapeutic, Inc. and Leukosite Inc. Dr. Springer has been Latham Family Professor at Department of Pathology at Center for Blood Research Harvard Medical School since 1989 and Professor of Medicine at Boston Children’s Hospital since 2011. Dr. Springer serves at AlloCyte Pharmaceuticals AG. He has also served as Senior Investigator in the Program in Cellular and Molecular Medicine at Boston Children’s Hospital since 2012. Dr. Springer serves as Member of Scientific Advisory Board at Scholar Rock Holding Corp. and had been its Director since October 2012 until May 22, 2019. He is a Co-founder and serves as a Director of Scholar Rock, Inc. until May 2019. He serves as Co-Chair of Scientific Advisory Board of Scholar Rock, Inc. He serves as Director and Member of Scientific Advisory Board of Morphic Rock Therapeutic, Inc. He serves as a Member of Scientific Advisory Board of Ab Initio Biotherapeutics, Inc. and Scholar Rock, Inc. He served as a Member of Scientific Advisory Board at Moderna Therapeutics, Inc. He serves as an Independent Director at Selecta Biosciences, Inc. since June 2016 and has been its Member of Scientific Advisory Board since December 2008. He is Founder and Director of Seismic Therapeutic, Inc. and serves as its Advisor. He serves as a Member of the National Academy of Sciences and his honors include the Crafoord Prize, the American Association of Immunologists Meritorious Career Award, the Stratton Medal from the American Society of Hematology and the Basic Research Prize from the American Heart Association. He served as a Director of Moderna Therapeutics, Inc. Dr. Springer served as Member of Scientific Advisory Board at Takeda Vaccines (Montana), Inc. He served as a Director of Leukosite Inc., since December 1997. Dr. Springer received B.S. in Biochemistry from University of California, Berkeley and Ph.D. in Biochemistry & Molecular Biology from Harvard University and also holds a B.A. in Biochemistry from the University of California, Berkeley.
Positions
- Company NameTectonic Therapeutic, Inc.Stock CodeTECXPositionIndependent DirectorColleagues
- ASAlise S. ReicinPresident, CEO, Secretary & Director
- FNFrancois NaderIndependent Chair of the Board
- DLDaniel LochnerChief Financial Officer
- MKMarcella Kuhlman RuddyChief Medical Officer
- WAWashington AlvesSenior Vice President of Technical Operations
- PMPeter McNamaraChief Scientific Officer
- PPPraveen P. TipirneniIndependent Director
- PBPhillip B. DonenbergIndependent Director
